Detalhe da pesquisa
1.
A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression.
Int J Cancer
; 152(2): 308-319, 2023 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054558
2.
The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial.
J Neurooncol
; 164(3): 749-755, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37787906
3.
Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses.
J Neurooncol
; 164(3): 607-616, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37728779
4.
Incurring detriments of unplanned readmission to the intensive care unit following surgery for brain metastasis.
Neurosurg Rev
; 46(1): 155, 2023 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37382699
5.
Unplanned intensive care unit readmission after surgical treatment in patients with newly diagnosed glioblastoma - forfeiture of surgically achieved advantages?
Neurosurg Rev
; 46(1): 30, 2023 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36593389
6.
Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS.
J Neurooncol
; 159(1): 95-101, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35704157
7.
Perioperative red blood cell transfusion is associated with poor functional outcome and overall survival in patients with newly diagnosed glioblastoma.
Neurosurg Rev
; 45(2): 1327-1333, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34480318
8.
Tumor-associated epilepsy in patients with brain metastases: necrosis-to-tumor ratio forecasts postoperative seizure freedom.
Neurosurg Rev
; 45(1): 545-551, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33988803
9.
MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA-09 trial.
Int J Cancer
; 148(7): 1695-1707, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33113214
10.
Red blood cell distribution width to platelet ratio substantiates preoperative survival prediction in patients with newly-diagnosed glioblastoma.
J Neurooncol
; 154(2): 229-235, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34347223
11.
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Lancet
; 393(10172): 678-688, 2019 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30782343
12.
Newly diagnosed glioblastoma in geriatric (65 +) patients: impact of patients frailty, comorbidity burden and obesity on overall survival.
J Neurooncol
; 149(3): 421-427, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32989681
13.
Analysis of Serum miRNA in Glioblastoma Patients: CD44-Based Enrichment of Extracellular Vesicles Enhances Specificity for the Prognostic Signature.
Int J Mol Sci
; 21(19)2020 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33003586
14.
Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial.
Lancet Oncol
; 20(10): 1444-1453, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31488360
15.
Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial.
J Neurooncol
; 144(3): 501-509, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31325144
16.
Correction to: Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses.
J Neurooncol
; 165(2): 387, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37921974
17.
Prognostic factors in recurrent glioblastoma patients treated with bevacizumab.
J Neurooncol
; 129(1): 93-100, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27193554
18.
Targeting pharmacoresistant epilepsy and epileptogenesis with a dual-purpose antiepileptic drug.
Brain
; 138(Pt 2): 371-87, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25472797
19.
Carmustine (BCNU) plus Teniposide (VM26) in recurrent malignant glioma.
Oncology
; 86(5-6): 369-72, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24942787
20.
Patients with Leptomeningeal Carcinomatosis and Hydrocephalus-Feasibility of Combined Ventriculoperitoneal Shunt and Reservoir Insertion for Intrathecal Chemotherapy.
Curr Oncol
; 31(5): 2410-2419, 2024 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38785461